meloxicam/Finding
One finding, on its own
A single claim from the graph, with the evidence strength computed from its study, the sentence it was drawn from, and the paper. This address does not change.
Increases time to first postoperative analgesic request
ModerateEvidence strength: moderate. Human evidence with one recorded weakness, or capped at moderate by its design or by unread numbers.Finding“Time from EOS to first use of opioid rescue medication (via IV or oral administration) was significantly longer with meloxicam IV versus placebo (P =.0003) (Table 4).”
Quoted verbatim from Safety and Efficacy of Perioperative Intravenous Meloxicam for Moderate-to-Severe Pain Management in Total Knee Arthroplasty: A Randomized Clinical Trial.. - Study
- RCT
- Dose
- 30 mg IV bolus before incision, then every 24 hours
- Population
- Adults undergoing elective primary total knee arthroplasty; both arms received multimodal analgesia (oral acetaminophen, gabapentin, tranexamic acid, bupivacaine infiltration)
Safety and Efficacy of Perioperative Intravenous Meloxicam for Moderate-to-Severe Pain Management in Total Knee Arthroplasty: A Randomized Clinical Trial.2021PMID:33502533Industry fundedPermalink
Keep reading
- Everything the graph holds on meloxicam
- Every compound studied against Time to first postoperative analgesic request
- How to read the evidence strength and the marks
To cite this finding: https://catalystproject.ai/e/01M45R0XB6GFNA23J1XDRTS8P5